Related Experiment Videos
Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis
1Division of Pathology, School of Pathological Sciences, Royal Victoria Infirmary, University of Newcastle upon Tyne, U.K.
The Journal of Pathology
|July 1, 1996
Summary
Transforming growth factor-alpha (TGF alpha) levels increase during rat liver cancer development, while its receptor (EGFr) decreases. This suggests the TGF alpha/EGFr system is crucial for promoting and sustaining hepatocellular carcinoma proliferation.
Area of Science:
- Hepatology
- Oncology
- Molecular Biology
Background:
- Hepatocarcinogenesis involves complex molecular changes.
- The role of growth factors in liver cancer progression requires further elucidation.
Purpose of the Study:
- To investigate the role of transforming growth factor-alpha (TGF alpha) and its receptor, epidermal growth factor receptor (EGFr), in diethylnitrosamine-induced hepatocarcinogenesis in rats.
- To correlate TGF alpha and EGFr levels with hepatocyte proliferation during liver tumor development.
Main Methods:
- Female Wistar rats were exposed to diethylnitrosamine for 10 weeks.
- Liver tissue was analyzed at 10, 16, and 19 weeks post-exposure.
- Levels of TGF alpha and EGFr were quantified using Western blotting and immunohistochemistry.
- Immunoreactivity was correlated with hepatocyte proliferation indices.
Main Results:
- TGF alpha immunoreactivity increased with the severity of dysplasia and was elevated in dysplastic nodules and carcinomas.
- Perivenular TGF alpha immunoreactivity initially increased then decreased as dysplasia progressed.
- Immunodetectable EGFr levels significantly decreased in cancerous tissue compared to normal controls.
- Up-regulation of TGF alpha and down-regulation of EGFr correlated positively and negatively, respectively, with hepatocyte proliferation.
Conclusions:
- The TGF alpha/EGFr ligand-receptor system appears to play a significant role in the promotion and progression of hepatocellular carcinoma.
- TGF alpha may stimulate continued proliferation in established liver tumors.